RESEARCH-USE BIOSIMILAR ANTIBODY
Rinucumab
Monoclonal antibody · IgG4
Rinucumab (REGN 2176) is an anti-PDGFR-β antibody. Rinucumab is used for research on neovascular age-related macular degeneration.
TARGETPDGFRB
YMonoclonal antibody
CATALOGSC-BS-213
CATALOG NUMBERSC-BS-213
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rinucumab (REGN 2176) is an anti-PDGFR-β antibody. Rinucumab is used for research on neovascular age-related macular degeneration.
Rinucumab is a recombinant research-use antibody directed against PDGFRB.